Search Results
Displaying 731 - 740 of 1157
… that supply it. The spinal cord is the bundle of nerves and nerve fibers that sends and receives signals from the brain. Infarction means death of tissue that happens when … will be safe and effective for everyone using them. For information about participating in clinical research, visit …
… Extramural Programs at National Institute of Neurological Disorders and Stroke ( NINDS ) managing a portfolio of grants …
… therapy? If you are an academic or small business concern and are not sure which program to apply to for your therapy … my therapeutic in my application? How can I be sure the information in my application will remain confidential? … purposes only and are reviewed in closed private (non-public) sessions by reviewers who are under strict …
… thousand people. Altogether, around 7,000 known rare and ultra-rare diseases affect 30 million people in the U.S. … 283 KB) (pdf, 283 KB)) will include scientific background information supporting the gene-therapy product/therapeutic … Forms of ALS Neil Alan Shneider Columbia University Health Sciences U01 Amyotrophic Lateral Sclerosis (ALS) …
… in the NINDS Clinical Trials Unit (Quality Assurance and Data Management Office). As a Protocol Monitoring Specialist, he provides auditing and monitoring expertise for intramural NINDS clinical trials … in events that can be reduced by targeted trainings and education and ultimately improves the safety of participants …
… contact the NINDS Office of Training, Career Development and Workforce Development if they are in doubt about their … to Independence Awards (K99/R00) (pdf, 112 KB) for more information. NIH has a provision to extend the K99/R00 … their dissertation). Applications that do not contain this information will not be considered for funding. When …
… Forum addresses the importance of relationships between public, private, and nonprofit stakeholders to … Sciences , Foundation for the National Institutes of Health , and Prevail Therapeutics . NINDS Program Director … research that will provide a greater understanding of the brain and nervous system and for new and better treatments …
… in which nonprofit leaders can network with colleagues and engage in discussions with NINDS staff. This year , … emerging field of gene-targeted treatments for multiple neurological conditions. This cutting-edge area of science … for the development of new therapies—particularly for disorders for which other drugs have had limited effects. …
… Dashboard. September 1, 2023. Available at https://www.cdc.gov/als/dashboard/index.html[1 ]. Accessed September 27, … 2022 Sep 21. PMID: 36129998 . (Biogen Pharmaceuticals; ClinicalTrials.gov numbers, NCT02623699, NCT03070119) … PMID: 32640130 . (Biogen Pharmaceuticals; Clinicaltrials.gov number NCT02623699) U.S. Food and Drug …
… - Preclinical Screening Platform for Pain program, and Epilepsy Therapy Screening Program. … and neuroimmune interactions following traumatic brain injury as well as mechanisms leading to neuropathic … on the neurochemical basis of behavior in the developing brain. She has served as a member of several permanent and …